Inspire Medical Systems (NYSE: INSP) reported Q3 EPS of $0.60, $0.54 better than the analyst estimate of $0.06. Revenue for the quarter came in at $203.2 million versus the consensus estimate of $197.59 million.

GUIDANCE:

Inspire Medical Systems sees FY2024 EPS of $1.20-$1.40, versus the consensus of $0.74. Inspire Medical Systems sees FY2024 revenue of $793-798 million, versus the consensus of $795.1 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.